These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8695922

  • 21. The topoisomerase inhibitors camptothecin and etoposide induce a CD95-independent apoptosis of activated peripheral lymphocytes.
    Ferraro C, Quemeneur L, Fournel S, Prigent AF, Revillard JP, Bonnefoy-Berard N.
    Cell Death Differ; 2000 Feb; 7(2):197-206. PubMed ID: 10713734
    [Abstract] [Full Text] [Related]

  • 22. Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells.
    Kataoka S, Naito M, Tomida A, Tsuruo T.
    Exp Cell Res; 1994 Nov; 215(1):199-205. PubMed ID: 7957669
    [Abstract] [Full Text] [Related]

  • 23. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K, Petersen BO, Falck J, Helin K, Jensen PB, Sehested M.
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [Abstract] [Full Text] [Related]

  • 24. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
    Oizumi S, Isobe H, Ogura S, Ishida T, Yamazaki K, Nishimura M, Kawakami Y, Dosaka-Akita H.
    Anticancer Res; 2002 Apr; 22(6C):4029-37. PubMed ID: 12553028
    [Abstract] [Full Text] [Related]

  • 25. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
    Wong ML, Hsu MT.
    J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235
    [Abstract] [Full Text] [Related]

  • 26. Detection of apoptosis induced by topoisomerase inhibitors and serum deprivation in syrian hamster embryo cells.
    Alexandre S, Rast C, Nguyen-Ba G, Vasseur P.
    Exp Cell Res; 2000 Feb 25; 255(1):30-9. PubMed ID: 10666331
    [Abstract] [Full Text] [Related]

  • 27. Lamellarin D: a novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug efflux.
    Vanhuyse M, Kluza J, Tardy C, Otero G, Cuevas C, Bailly C, Lansiaux A.
    Cancer Lett; 2005 Apr 28; 221(2):165-75. PubMed ID: 15808402
    [Abstract] [Full Text] [Related]

  • 28. Topoisomerase inhibitors have potent differentiation-inducing activity for human and mouse myeloid leukemia cells.
    Nakaya K, Chou S, Kaneko M, Nakamura Y.
    Jpn J Cancer Res; 1991 Feb 28; 82(2):184-91. PubMed ID: 1848545
    [Abstract] [Full Text] [Related]

  • 29. The mechanism of epipodophyllotoxin-induced thymocyte apoptosis: possible role of a novel Ca(2+)-independent protein kinase.
    Ye X, Georgoff I, Fleisher S, Coffman FD, Cohen S, Fresa KL.
    Cell Immunol; 1993 Oct 15; 151(2):320-35. PubMed ID: 8402939
    [Abstract] [Full Text] [Related]

  • 30. Selective inhibition of topoisomerase II by ICRF-193 does not support a role for topoisomerase II activity in the fragmentation of chromatin during apoptosis of human leukemia cells.
    Beere HM, Chresta CM, Hickman JA.
    Mol Pharmacol; 1996 May 15; 49(5):842-51. PubMed ID: 8622634
    [Abstract] [Full Text] [Related]

  • 31. Differential effect of camptothecin treatment on topoisomerase II alpha expression in ML-1 and HL-60 leukemia cell lines.
    Nair J, Traganos F, Tse-Dinh YC.
    Anticancer Res; 2000 May 15; 20(6B):4183-8. PubMed ID: 11205246
    [Abstract] [Full Text] [Related]

  • 32. DNA fragmentation induced by protease activation in p53-null human leukemia HL60 cells undergoing apoptosis following treatment with the topoisomerase I inhibitor camptothecin: cell-free system studies.
    Shimizu T, Pommier Y.
    Exp Cell Res; 1996 Aug 01; 226(2):292-301. PubMed ID: 8806433
    [Abstract] [Full Text] [Related]

  • 33. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
    Grant S, Turner AJ, Bartimole TM, Nelms PA, Joe VC, Jarvis WD.
    Oncol Res; 1994 Aug 01; 6(2):87-99. PubMed ID: 7949469
    [Abstract] [Full Text] [Related]

  • 34. Topoisomerase inhibitors induce apoptosis in thymocytes.
    Onishi Y, Azuma Y, Sato Y, Mizuno Y, Tadakuma T, Kizaki H.
    Biochim Biophys Acta; 1993 Jan 17; 1175(2):147-54. PubMed ID: 8380339
    [Abstract] [Full Text] [Related]

  • 35. Chiral ruthenium(II) complexes with phenolic hydroxyl groups as dual poisons of topoisomerases I and IIα.
    Zhang P, Wang J, Huang H, Qiao L, Ji L, Chao H.
    Dalton Trans; 2013 Jun 28; 42(24):8907-17. PubMed ID: 23661230
    [Abstract] [Full Text] [Related]

  • 36. Mesenchymal stem cells exhibit resistance to topoisomerase inhibition.
    Nicolay NH, Rühle A, Perez RL, Trinh T, Sisombath S, Weber KJ, Schmezer P, Ho AD, Debus J, Saffrich R, Huber PE.
    Cancer Lett; 2016 Apr 28; 374(1):75-84. PubMed ID: 26876302
    [Abstract] [Full Text] [Related]

  • 37. The inhibition of cellular recovery in human tumour cells by inhibitors of topoisomerase.
    Musk SR, Steel GG.
    Br J Cancer; 1990 Sep 28; 62(3):364-7. PubMed ID: 2169851
    [Abstract] [Full Text] [Related]

  • 38. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
    Zwelling LA, Chan D, Hinds M, Mayes J, Silberman LE, Blick M.
    Cancer Res; 1988 Dec 01; 48(23):6625-33. PubMed ID: 2846155
    [Abstract] [Full Text] [Related]

  • 39. Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.
    Ritke MK, Allan WP, Fattman C, Gunduz NN, Yalowich JC.
    Mol Pharmacol; 1994 Jul 01; 46(1):58-66. PubMed ID: 8058057
    [Abstract] [Full Text] [Related]

  • 40. Exposure to low concentrations of etoposide reduces the apoptotic capability of leukaemic cell lines.
    Liu WM, Oakley PR, Joel SP.
    Leukemia; 2002 Sep 01; 16(9):1705-12. PubMed ID: 12200685
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.